Godolphin (ASX:GRL) values Narraburra at A$12.5m in Matrix spinout

A yttrium-heavy resource, an in-specie distribution and a 150x price gap tell the real story here

Godolphin Resources (ASX:GRL) has confirmed the capital structure and valuation for the proposed spinout of its Narraburra Rare Earths Project into a new ASX-listed vehicle called Matrix Critical Minerals. The Matrix IPO is targeting a raise of A$8 million to A$12 million at A$0.20 per share, with listing anticipated for the second half of 2026. Narraburra itself has been attributed a value of A$12.5 million on transfer into Matrix.

The mechanics are worth reading twice. Godolphin will receive 62.5 million consideration shares in Matrix, then distribute 50 million of those to existing GRL holders on a pro-rata in-specie basis, roughly one Matrix share for every 17 GRL shares held. Godolphin keeps 12.5 million shares, or about 10% to 12% of Matrix on admission.

The strategic logic is that Narraburra has been buried inside a GRL market cap that the market prices as a gold explorer. A dedicated rare earths listing gives the yttrium story its own audience, its own funding pathway and, hopefully, its own multiple.

Why the yttrium angle matters more than the headline valuation

Narraburra hosts a 94.9 million tonne JORC 2012 resource, with a higher-grade core of 20 million tonnes at 1,079ppm total rare earth oxide. What sets it apart is the product mix. Testwork has shown the deposit produces a mixed rare earth carbonate roughly 18.7% yttrium oxide by weight.

That matters because yttrium is one of the heavy rare earths China restricted in April 2025. Benchmark reported ex-China yttrium oxide at US$1,150 per kilogram in March 2026 and US$1,575 in April, against a Chinese domestic price averaging US$10 per kilogram this year. That is a 150-fold price divergence between the two markets.

We think the yttrium exposure is the real reason a separate listing has a chance of working. A rare earths investor screening for non-Chinese heavy rare earths supply will not find Narraburra by scanning ASX gold explorers.

What GRL shareholders actually get out of the transaction

The in-specie distribution is a genuine return of value on paper. GRL shareholders receive Matrix shares directly, retain full exposure to Lewis Ponds, and get a priority allocation in the Matrix IPO itself. At A$0.20 per share, the 50 million distributed shares carry an implied value of A$10 million before any market re-rating.

The skeptical read is that spinouts only unlock value when the parent was genuinely under-priced for the asset and the market believes the new vehicle can fund itself. An A$8 million minimum raise is modest, and Matrix will need to spend that carefully before the next raise. Dilution risk does not disappear, it simply moves off GRL’s balance sheet.

The listing timeline is the near-term catalyst to watch

The in-principle ASX application is being finalised and listing is targeted for H2 2026. Between now and then, the prospectus, tax rulings, shareholder approvals and final due diligence all need to land.

MST Financial is lead manager on the raise, which is a credible appointment for a project of this size. What we would want to see before listing is the register quality, particularly whether specialist rare earths funds show up on the cornerstone list.

The Investors Takeaway for Godolphin Resources

The Matrix IPO is a clean example of a small explorer trying to unlock a strategic asset that its host market cap does not credit. The yttrium exposure, priced 150 times higher outside China than inside it, is a genuinely differentiated hook.

The harder question is whether Matrix lists at, above or below its A$12.5 million attributed value, because that is where the market’s real verdict on the spinout thesis will show up. Investors can find more in-depth coverage of ASX-listed rare earths names at stocksdownunder.